E

Eir Ventures

7 employees

EIR Ventures is a new Life Science Venture Group in the Nordics.

Investor insights

Sectors invested in

Biotechnology7

Health Care3

Pharmaceutical2

Immuno-oncology2

Pharmaceuticals1

Clinical Trials1

Test and Measurement1

Biopharma1

Therapeutics1

Oncology1

Disease1

Science1

Rare disease1

Biology1

Medicine1

Technology1

Drug Development1

Immunotherapy1

Personalized medicine1

Biometrics1

Funding rounds participated in

$28M sweet spot round size

Most of their 7 investments are in rounds between $4.8M and $32M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Date founded

2020

Investments made

H

Henlez raised $985K on October 24, 2022

Investors: Karolinska Development and Eir Ventures

P

Pretzel Therapeutics raised $73M on September 12, 2022

Investors: GU Ventures, The Invus Group, GV, Cambridge Enterprise, Cambridge Innovation Capital plc, ARCH Venture Partners, HealthCap, Karolinska Development and Eir Ventures

S

Synklino raised $32M on June 8, 2022

Investors: Vækstfonden, LD INVEST, PKA and Eir Ventures

C

Cinclus Pharma raised $24M on May 20, 2022

Investors: Trill Impact, Linc AB, Fjärde AP-fonden and Eir Ventures

S

Scenic Biotech raised $31M on March 10, 2022

Investors: Oxford Sciences Innovation, BGV (BioGeneration Ventures), BioMedPartners, Inkef and Eir Ventures

S

Strike Pharma AB raised $4.8M on February 22, 2022

Investors: Flerie Invest and Eir Ventures

S

Synklino raised undisclosed on September 29, 2020

Investors: Vækstfonden and Eir Ventures